GSK Investigational Site — Moorestown, New Jersey

GSK Investigational Site is a clinical research site located in Moorestown, New Jersey, United States 08057.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 5 clinical trials.

Therapeutic areas: Epilepsy, Major Depressive Disorder (MDD), Pulmonary Disease, Chronic Obstructive.

Sponsors: GlaxoSmithKline.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 5 clinical trials on record. Their work covers Epilepsy, Major Depressive Disorder (MDD), Pulmonary Disease, Chronic Obstructive.

Is GSK Investigational Site accredited by Crixeo Health?

GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.